Home > Perspectives on drugs: Hepatitis C treatment for injecting drug users.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2015) Perspectives on drugs: Hepatitis C treatment for injecting drug users. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 7 p.

[img]
Preview
PDF (Hepatitis C treatment for injecting drug users) - Published Version
278kB

URL: http://www.emcdda.europa.eu/topics/pods/hepatitis-...

Transmitted through the sharing of needles, syringes and other injecting equipment, hepatitis C is the most common infectious disease among injecting drug users in Europe today.In this analysis, the EMCDDA looks at some of the positive advances in treating the disease, including a new generation of medicines.

1. Analysis
2. Video
3. Facts and figures
4. New medicines


Item Type:Evidence resource
Publication Type:Guideline
Drug Type:Opioid
Intervention Type:AOD disorder drug therapy, AOD disorder treatment method, AOD disorder harm reduction
Source:EMCDDA
Date:May 2015
Pages:7 p.
Publisher:European Monitoring Centre for Drugs and Drug Addiction
Corporate Creators:European Monitoring Centre for Drugs and Drug Addiction
Place of Publication:Lisbon
EndNote:View
Accession Number:HRB (Electronic Only)
Subjects:G Health and disease > Disorder by cause > Communicable disease > Hepatitis C
HJ Treatment method > Drugs and alcohol disorder treatment method
J Health care, prevention and rehabilitation > Treatment and maintenance > Treatment factors
T Demographic characteristics > Intravenous / injecting drug user
VA Geographic area > Europe

Repository Staff Only: item control page